review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1080/08880010701640390 |
P8608 | Fatcat ID | release_v6lxgeajhvf2vokzovcesowy24 |
P698 | PubMed publication ID | 18092252 |
P2093 | author name string | Aykan Ozguven | |
Dilek Gunes | |||
Emre Cecen | |||
Gulersu Irken | |||
Kamer Mutafoglu Uysal | |||
Nur Olgun | |||
P2860 | cites work | Veno-occlusive disease with multi-organ involvement following actinomycin-D. | Q33337478 |
Engraftment syndrome following hematopoietic stem cell transplantation | Q34298239 | ||
Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome | Q34481791 | ||
Veno-occlusive disease of the liver after chemotherapy for rhabdomyosarcoma: case report with a review of the literature | Q40496445 | ||
Veno-occlusive disease of the liver in right-sided Wilms' tumours | Q42537708 | ||
Veno-occlusive disease of the liver in children treated for Wilms tumor. | Q42548268 | ||
Venoocclusive disease of the liver after chemotherapy with vincristine, actinomycin D, and cyclophosphamide for the treatment of rhabdomyosarcoma. A report of the Intergroup Rhabdomyosarcoma Study Group. Childrens Cancer Group, the Pediatric Oncolog | Q42549090 | ||
Systemic capillary leak syndrome after granulocyte colony-stimulating factor (G-CSF). | Q44401469 | ||
Age is a risk factor for chemotherapy-induced hepatopathy with vincristine, dactinomycin, and cyclophosphamide | Q44895894 | ||
Severe hepatic toxicity after treatment with vincristine and dactinomycin using single-dose or divided-dose schedules: a report from the National Wilms' Tumor Study | Q45062562 | ||
P433 | issue | 8 | |
P921 | main subject | chemotherapy | Q974135 |
rhabdomyosarcoma | Q1898141 | ||
P304 | page(s) | 615-621 | |
P577 | publication date | 2007-12-01 | |
P1433 | published in | Pediatric Hematology and Oncology | Q7159205 |
P1476 | title | Veno-occlusive disease in a child with rhabdomyosarcoma after conventional chemotherapy: report of a case and review of the literature | |
P478 | volume | 24 |
Q91691324 | Adjuvant recombinant thrombomodulin therapy for hepatopathy induced by vincristine, actinomycin D, and cyclophosphamide in pediatric rhabdomyosarcoma: A case report |
Q43287362 | Hepatic Sinusoidal Obstruction Syndrome in a child after chemotherapy for medulloblastoma |
Q37414178 | Hepatic sinusoidal obstruction syndrome during chemotherapy for childhood medulloblastoma: report of a case and review of the literature. |
Q33393867 | Hepatopathy-thrombocytopenia syndrome (HTS) after actinomycin-D therapy: report of three cases and review of the literature |
Q90058452 | Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS/VOD after haematopoietic cell transplantation |
Q37367452 | Severe Hepatic Sinusoidal Obstruction Syndrome in a Child Receiving Vincristine, Actinomycin-D, and Cyclophosphamide for Rhabdomyosarcoma: Successful Treatment with Defibrotide |
Q47657117 | Sinusoidal Obstruction Syndrome during Treatment for Wilms' Tumor: A Life-threatening Complication |
Q61810894 | Sinusoidal obstruction syndrome in a paediatric patient with acute lymphoblastic leukaemia after completion of reinduction therapy according to ALL Intercontinental Berlin-Frankfurt-Münster 2009 |
Q37062862 | The protective role of parsley extract against vincristine mutagenicity in Drosophila melanogaster |
Search more.